Anbio Biotechnology (NASDAQ:NNNN) Stock Price Down 5.8% – What’s Next?

Anbio Biotechnology (NASDAQ:NNNN) was down 5.8% during trading on Friday. The stock traded as low as $4.34 and last traded at $4.3540. 9,671 shares traded hands during trading, a decline of 88% from the average daily volume of 78,563 shares. The stock had previously closed at $4.62.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings downgraded shares of Anbio Biotechnology from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Wednesday, July 29th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat, Anbio Biotechnology presently has a consensus rating of “Sell”.

Anbio Biotechnology Stock Down 5.5%

The stock has a fifty day moving average price of $7.25 and a two-hundred day moving average price of $16.41.

Anbio Biotechnology Company Profile

Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.